Domain Not Resolving

Amazon

Content Delivery Network

nginx

Microsoft Exchange Online

Office 365 Mail

Google

Microsoft Azure DNS

Google Cloud

Senior Manager, Payroll and Equity

Kim Zacharias

Senior Manager, Compensation & Benefits

Laurie Price

Engineering

Emily Cooper

NeuroImmunology Specialist

Susan Zemaitis

Sr. Supply Chain Planning Manager

Ethan Rudolph

Director, Analytical Sciences

Jihong Wang

Jörn Drappa

Head of R&D,Chief Medical Officer

Soraya Madani

Vice President, Head of Portfolio Management and Regulatory Affairs

Bing Yao

Aaron Ren

Head of Business Development and Operations

Timothy Walbert

Founder, Chairman, President & CEO

Brian K. Beeler

Executive Vice President, General Counsel

Biotechnology Acquired Companies With Less Than $1B in Revenue

Washington DC Metro Area Companies (Top 10K)

Acquired Biotechnology Companies

Health Diagnostics Acquired Companies With More Than 10 Employees

Viela Bio is a clinical-stage biotechnology company pioneering and advancing treatments for severe inflammation and autoimmune diseases. The Company’s portfolio selectively targets shared critical pathways that are the root cause of disease. Led by a team of global leaders in inflammation and autoimmunity, Viela Bio strives to be a fully integrated biotechnology company, helping millions of patients worldwide. 

Viela Bio is located in Gaithersburg, Maryland.

Post-IPO Equity - Viela Bio

HBM Healthcare Investments

Series B - Viela Bio

6 Dimensions Capital

AstraZeneca

Boyu Capital

Hillhouse Investment

Series A - Viela Bio

Gaithersburg

Maryland

United States

North America

Viela Bio

Ilt7 binding molecules and methods of using the same

Anti-cd19 binding agents for the treatment and prevention of immune mediated …

Cd40l-specific tn3-derived scaffolds for the treatment and prevention of …

AstraZeneca Disputes Claims It Bullied Viela Bio into Sale

Cd40l antagonist and uses thereof in the treatment of lupus nephritis

Use of an anti-cd19 antibody to treat autoimmune disease

Hedge Funds Cautiously Watching Viela Bio, Inc. (VIE)

PANTHERx® Chosen as Exclusive Rare Pharmacy Partner by Vi...

HTML5

Google Compute Engine

DigiCert

Wordpress

Google Analytics

Google Fonts

GoDaddy Premium DNS

Google Maps API

Office 365

F5 NGINX

Viela Bio is a biotechnology company focused on developing and commercializing transformative medicines for severe autoimmune diseases by selectively targeting shared critical pathways that underlie multiple autoimmune diseases.

industry_trends_dossier

news_impact_assignment_basic

key_people

company_dossier

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

network

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

events

strategic_challenges

network_mapping

industry_trends

transactions_dossier

strategic_challenges_dossier

network_onboarding

company_summary

regulatory_analysis

industry_analysis

swot_dossier

competition_analysis

financial_legal_advisories

merger_acquisitions

swot_analysis

financial_analysis

news_advanced

purchaser_profile

news_impact_assignment_advanced

signals

news_processing_advanced

financial_statements

private_financials

funding_rounds_analysis

company_structure

crunchbase_trigger

crunchbase_profile

li_profile

translate_crunchbase_fundingrounds

peers

news_basic

valuation

customer_profile

industry trends dossier	dataroom
company dossier	dataroom
network	dataroom
network mapping	dataroom
transactions dossier	dataroom
network onboarding	dataroom
news impact assignment basic	general	Mar 7, 2024 8:24 AM	61d00a5e
public peers	general
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Mar 7, 2024 8:24 AM	795ad9de
company summary	general
news advanced	general
news impact assignment advanced	general
signals	general
news processing advanced	general
crunchbase trigger	general	Oct 30, 2024 1:02 PM	573f976a
crunchbase profile	general	Oct 30, 2024 11:39 PM	9dfdae93
li profile	general
translate crunchbase fundingrounds	general	Nov 6, 2024 3:12 PM	e8686057
peers	general
news basic	general	Mar 7, 2024 8:24 AM	cb8813d9
events	markdown
bundesanzeiger	filings
regulatory analysis	company_analysis
industry analysis	company_analysis
competition analysis	company_analysis
financial legal advisories	company_analysis
merger acquisitions	company_analysis
swot analysis	company_analysis
financial analysis	company_analysis
funding rounds analysis	company_analysis
company structure	company_analysis
purchaser profile	merger_acquisitions
private financials	financials
customer profile	customers

VIEL

COM:VIELABIO

Viela Bio